News

Hansa Biopharma Data At The 2025 PNS Annual Meeting Demonstrates Potential Of Imlifidase In The Treatment Of GBS
Hansa communicated the results from the 15-HMedIdeS-09 study in December 2024. Professor Shahram Attarian, Head of Department of Neuromuscular Diseases and ALS, Hopitaux Universitaires de Marseille ...
Apple lays groundwork for iPhone brain control technology
In a press release this morning, Apple announced its suite of new accessibility features coming to the iPhone later ...
Apple unveils iOS 19 accessibility features: Magnifier for Mac, App Store labels, more
Ahead of WWDC kicking off in June, Apple today has officially unveiled this year’s new accessibility features for iPhone, ...
AirCar flying car to be delivered in early 2026
After a long period of development, the AirCar flying car is finally coming onto the market. However, it is not suitable for ...
Tempertm More, ADAMA's New Broad Spectrum Herbicide, Receives Registration In USA
Next-generation weed control solution powered by Sesgama® Formulation Technology offers farmers better planning, fewer applications, an ...
Temper™ More, ADAMA's New Broad Spectrum Herbicide, Receives Registration in USA
ADAMA Ltd. (SZSE: 000553), a leading global crop protection company, announced that its new herbicide, Temper™ More, has ...